(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Report for Q3 2026

Summary by 6ix AI

The report confirms that the financial data presented is accurate and complete, with the board of directors taking legal responsibility for its contents. Key financial highlights include total revenue and net profit figures, which reflect the company's performance compared to the same period last year. The report also includes information on shareholder equity and significant changes in assets and liabilities.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries